Anhedonia: A transnosological concept?;Anedonia: Un concetto transnosografico?

Minerva Psichiatrica

Volumn 46, Issue 4, 2005, Pages 285-300

  Pelizza, L ^a,b  

^a AO Istituti Ospitalieri   (Italy)

^b NONE   (Italy)

Author keywords

Addictive disorders; Anhedonia; Dopamine; Major depression; Schizophrenia

Indexed keywords

ADDICTION; ANHEDONIA; DISEASE CLASSIFICATION; DRUG DEPENDENCE; HUMAN; MAJOR DEPRESSION; MENTAL DISEASE; NEUROBIOLOGY; REVIEW; SCHIZOPHRENIA; SYMPTOMATOLOGY;

EID: 32244443735     PISSN: 03749320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (62)

1. Baudelaire C. I fiori del male. Milano: Edizioni Garzanti; 1975.
2. Leone M. Gli impermeabili, soglie della sensibilità. www.golem.it; 2004.
3. Ribot J. La psychologie des sentiments. Paris: Felix Arcan; 1896.
4. Pinel P. Treatise on insanity. Sheffield: Cadell & Davis; 1806.
5. Silverstone P. Is anhedonia a good measure of depression? Acta Psychiatr Scand 1991; 83: 249-50.
6. Ettenberg A. Anhedonia. In: Costello C, editor. Symptoms of schizophrenia. New York: Wiley; 1993.p. 121-44.
7. Koob G, Le Moal M. Drug abuse: hedonic omeostatic disregulation. Science 1997;278:52-8.
8. Bermanzhon P, Siris S. Akinesia: a syndrome common to parkinsonism, retarded depression and negative symptoms of schizophrenia. Compr Psychiatry 1992;33: 221-32.
9. Polese D, Amato De Serpis A, De Bartolomeis A. Anedonia: dai modelli sperimentali alla psicopatologia. It J Psychopathol 2000;6:1-36.
10. th ed. Washington DC: APA; 1994.
11. Willner P. Validity, reliability and utilità of the chronic-mild stress model of depression: a 10-years review and avaluation. Psychopharmacology (Berlin) 1997;134: 319-29.
12. Manna V, Daniele M, Pinto M. Disedonia: ruolo della disregolazione omeostatica edonica nelle dipendenze patologiche da sostanze ed in altri disturbi psicopatologici. Ital J Psychopathol 2003;9:1-42.
13. Olds J, Millner C. Positive reinforcement produced by electrical stimulation of the septal area and other regions of the rat brain. J Compar Physiol Psychol 1954; 47:419-27.
14. Wise R. The anhedonia hypotesis: mark III. Behav Brain Science 1985;8:178-86.
15. Stellar J, Stellar E. The neurobiology of motivation and reward. New York: Sprinter Verlag Edition; 1985.
16. Schallert T, Wischaw I, Ramirez V. Neurotrasmitters and the regulation of food intake. Progr Brain Res 1975;42:235-49.
17. Zurita A, Murna S, Molina V. An endogenous opiate mechanism seems to be involved in stress-induced anhedonia. Eur J Pharmachol 1996;299:1-7.
18. Pecina S, Berridge K. Brainstem mediates benzodiazepine enhancement of taste palatability: comparison of diazepam microinjections into fourth versus lateral ventricles. Brain Res 1996;727:22-30.
19. Berridge K. Food reward: brain substrates of wanting and liking. Neurosci Biobehav Rev 1996;20:1-25.
20. Bleuler E. Dementia praecox oder groupe der Schizophrenien. Leipzig: Deuticke; 1911.
21. Kraepelin E. Psichiatrie. 8th ed. Auflage: Bond; 1913-1919.
22. Andreasen N. Negative symptoms of schizophrenia: definition and reliability. Arch Gen Psychiatry 1982;39: 784-8.
23. Carpenter W. Deficit/non deficit forms of schizophrenia: the concept. Am J Psychiatry 1988;145:578-83.
24. rd ed. New York: APA; 1977.
25. Meehl P. Schizotaxia, schizotypy and schizophrenia. Am Psychol 1962;17:827-38.
26. Chapman L, Chapman J, Kwapil T. Putatively psychosis-prone subjects ten years later. J Abnorm Psychol 1994;130:171-83.
27. Crow T. Molecular pathology of schizophrenia: more than one disease process. BMJ 1980;280:66-8.
28. Loas G, Boyer P, Legrand A. Anhedonia and negative symptomatology in chronic schizophrenia. Compr Psychiatry 1996;37:5-11.
29. Blanchard I, Muesr K, Bellack A. Positive and negative affect and social functioning in schizophrenia. Schizophr Bull 1998;24:413-24.
30. Herbener E, Harrow M. The corse of anhedonia during 10 years of schizophrenic illness. J Abnorm Psychol 2002;111:237-48.
31. Myerson A. Anhedonia, part I: the loss of desire and satisfaction. J Nerv Ment Dis 1922;99:309-11.
32. Rado S. Psychoanalysis of behavior: collected papers. New York: Grume & Stratton; 1956.
33. Harrow M. Anhedonia and schizophrenia. Am J Psychiatry 1977;134:794-7.
34. Schurhoff F, Szoke A, Tircas C. Anhedonia in schizophrenia: a distinct familial subtype? Schizophr Res 2003;61:59-66.
35. Maggini C, Pelizza L, Marotta M, Raballo A, Paini M, Croci R. Anedonia e schizofrenia. Proceedings of the VII SOPSI National Congress; 2002, February 24-28; Rome, Italy.
36. Maggini C, Pintus A. Disturbi di personalità e schizofrenia. Noos 1998;13:159-73.
37. Pintus A, Maggini C. Schizoidia: il tramonto di un concetto. Noos 1998;13:175-84.
38. Clouston T. Clinical lectures on mental diseases. London: Churchill; 1896.
39. Bevan-Lewis W. A textbook of mental diseases. London: Churchill; 1899.
40. Van Praag H. The vital sindrome interview. Psychiatr Neurol Neurosurg 1965;68:329-40.
41. Klein D. Endogenomorphic depression. Arch Gen Psychiatry 1974;31:447-54.
42. Fawcett J. Clark D, Scheftner A. Differences between anhedonia and normal hedonic depressive states. Am J Psychiatry 1982;140:1027-30.
43. WHO. The ICD-10 classification of mental and behavioral disorders: clinical descriptions and diagnostic guidelines. Ginevra: WHO; 1992.
44. Joiner T, Brown J, Metalsky G. A test of the tripartite model's prediction of anhedonia's specificity to depression: patients with major depression versus patients with schizophrenia. Psychiatry Res 2003;119:243-50.
45. Lemke M, Puhl P, Koethe N. Psychomotor retardation and anhedonia in depression. Acta Psichiatr Scand 1999;99:252-6.
46. Oei T, Verhoeven W, Westenberg H. Anhedonia, suicide ideation and clexamethasone non-suppression in depressed patients. J Psychiatry Res 1990;24:25-35.
47. Maggini C, Pelizza L. Anedonia, ahulia-apatia e sintomi di base nella schizofrenia, nei disturbi dell'umore e d'ansia. Proceedings of the VI SOPSI National Congress; 2001, February 22-25; Rome, Italy.
48. Myerson A. The costitutional anhedonia personality. Am J Psychiatry 1946;22:774-9.
49. Meehl P. Hedonic capacity ten years later: some clarifications. In: Clark D, Fawcett J, editors. Anhedonia and affect deficit states. New York: PMA Publishing; 1987.p.202-32.
50. Kendler K. The structure of schizotypy: a pilot multi-trait study. Psychiatry Res 1991;36:19-36.
51. Akiskal H, Weise R. The clinical spectrum of so-called "minor depressions". Am J Psychother 1992;46:9-22.
52. Loas J. Vulnerabilità to depression: a model centered on anhedonia. J Affect Dis 1996;41:39-53.
53. Di Chiara G, Acquas E, Carboni E. Role of mesolimbic dopamine in the motivational effects of drug: brain dialysis and place preference studies. In: Willner P, Sheel-Kruger J editors. The mesolimbic dopamine system: from motivation to action. Chichester, UK: Wiley & son; 1991.p.151-4.
54. Koob G, Le H, Creese I. The D1 dopamine receptor antagonist SCH 23390 increases cocaine self-administration in the rat. Neurosci Let 1987;79:315-9.
55. Taylor J, Robbins T. Enhanced behavoiural control by conditioned reinforces following microinjections of d-amphetamine into nucleus accumbens. Psychopharmacology 1984;84:405-9.
56. Erb S, Shahan J, Steward J. Stress reinstates cocaine-seeking behavior after prolonged extincion and a daig free period. Psychopharmacology 1996;128:408-12.
57. Khantzian E. The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am J Psychiatry 1985;142:1259-64.
58. Koob G, Bloom F. Cellular and molecular mechanism of drug dependence. Science 1988;242:715-6.
59. Manna V, Di Rienzo A, Caccianotti B. Neurobiologia delle farmacodipendenze. Psichiatria, Scienze Umane 1997;17:367-79.
60. Cloninger C. A systematic method for clinical description and classification of personality variants. Arch Gen Psychiatry 1987;44:573-88.
61. Zuckermann M. Sensation seeking, risk taking and health. In: Janisse M editor. Individual differences, stress and health. New York: Springer-Verlag; 1988.p.83-97.
62. Gerra G, Zaimovic A, Timpano M, Zambelli U, Del Signore R, Brambilla F. Neuroendocrine correlates of temperamental traits in humans. Psychoneuroendocrinology 2000;25:479-96.